Alterations in the vascular extracellular matrix of granulocyte macrophage colony‐stimulating factor (GM‐CSF) ‐deficient mice
- 3 June 2003
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 17 (11) , 1451-1457
- https://doi.org/10.1096/fj.02-1035com
Abstract
GM-CSF takes part in the cytokine network regulating the metabolism of extracellular matrix (ECM) during atherogenesis. Since data also point to an effect of GM-CSF on the vascular ECM in general, the vascular collagenous matrix was studied in wild-type and GM-CSF-deficient mice. Histological examination revealed a disorganized vascular ECM in GM-CSF-deficient mice involving the collagenous matrix and elastic fiber system. As shown by electron microscopy, collagen bundles were disrupted and reduced. The diameter of fibrils varied widely. mRNA expression of collagens and related molecules was studied. Fibrillar collagens were markedly reduced, α1(I)procollagen to 16.5% of control levels α1(III)procollagen was abolished whereas the expression level of network-forming α1(VIII)procollagen was not altered. As shown by in situ hybridization, the number of collagen-expressing cells was reduced. Matrix metalloproteinases and their inhibitor 1 were not affected by GM-CSF deficiency. Our studies demonstrate that GM-CSF plays a major role in the cytokine network regulating the metabolism of vascular collagens. GM-CSF deficiency leads to an altered composition of the vascular collagenous matrix, i.e., reduced amount of fibrillar collagen, altered ratio of fibrillar and network-forming collagen, and failures in the fibrillogenesis. We suggest that GM-CSF is a basic requirement for the maintenance of vessel wall integrity and resilience.—Plenz, G., Eschert, H., Beissert, S., Arps, V., Sindermann, J. R., Robenek, H., Völker, W. Alterations in the vascular extracellular matrix of granulocyte macrophage colony-stimulating factor (GM-CSF) -deficient mice.Keywords
This publication has 31 references indexed in Scilit:
- Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosisExpert Opinion on Investigational Drugs, 2000
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Modulates the Expression of Type VIII Collagen mRNA in Vascular Smooth Muscle Cells and Both Are Codistributed During AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Enhanced Cytokine Production and Collagen Synthesis of Gingival Fibroblasts from Patients with Denture FibromatosisJournal of Dental Research, 1995
- Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary HomeostasisScience, 1994
- Human Granulocyte-Macrophage Colony-Stimulating Factor Lowers the Levels of Plasma Cholesterol with an Increase in mRNA for Very Low Density Lipoprotein Receptor in RabbitsaAnnals of the New York Academy of Sciences, 1994
- Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cellsAtherosclerosis, 1993
- Role of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Fibrosis Induced in Mice by BleomycinExperimental Lung Research, 1993
- Interleukin 1 and tumor necrosis factor‐α additively increase the levels of granulocyte‐macrophage and granulocyte colony‐stimulating factor (CSF) mRNA in human fibroblastsEuropean Journal of Immunology, 1989
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- The granulocyte—Macrophage colony stimulating factorsCell, 1985